Genentech wins FDA approval of bispecific blood cancer drug Lunsumio - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 61 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 68%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

Genentech/Roche and $BIIB line up bispecific antibodies against cancer

The first in a potential multibillion-dollar family of cancer-fighting drugs by Genentech Inc. could offer an off-the-shelf alternative to effective, but limited, cell therapies.

The treatment is called bispecific because the arms of the Y-shaped antibody, an artificial protein, can simultaneously link to two different players in the fight against cancer. That effectively offers a one-two punch against the disease. For now, the FDA approval gives doctors another tool beyond chimeric antigen receptor T cell, or CAR-T, therapies that have been lauded for their potency. CAR-Ts, such as Yescarta from Gilead Sciences Inc.'s Kite Pharma and Novartis AG's Kymriah, use a patient's own cells, which are re-engineered and infused back into them in a process that can take weeks.

Lunsumio — homegrown at Genentech research and early development, or gRED — is the first in what the company believes could be a family of bispecific antibodies that eventually could expand into first-line options for patients, not just for patients who have failed other therapies. "Both of these antibodies are new approaches for treating cancers," Laport said."They are off-the-shelf or ready-to-treat, unlike cell therapies with genetic engineering, and are given for a fixed duration, for a finite amount of time. Patients are less likely to develop side effects."

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 78. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Southwest reduces SFO, San Jose flight cancellations in return to normal - San Francisco Business TimesSouthwest Airlines Co. appears to be making good on a promise to resume its schedule after a week of mayhem for airline passengers in SFO, San Jose and around the country.
Fonte: SFBusinessTimes - 🏆 78. / 68 Consulte Mais informação »